Global Genomics Market Overview, Drivers, Restraints and Regional Analysis
- Get link
- X
- Other Apps
The study of human genes and chromosomes is known as genomics. It concentrates on genomic structure, function, evolution, mapping, and editing. The genome is an organism's genetic material, which includes deoxyribonucleic acid (DNA) (DNA). The information required to construct the entire human body is contained in DNA. The human genome is made up of 23 chromosomal pairs and 24000 genes. Structural genomics, functional genomics, and comparative genomics are all types of genomics research.
Global Genomics Market Drivers
The global genomics
market is predicted to develop because to an increase in new product
introductions. Contextual Genomics, for example, launched two molecular hotspot
assays for the detection of genomic alterations in blood and solid tumours in
January 2019. Rosetta Genomics Ltd. also announced OncoGxOne in May 2015. The
Next Generation Sequencing (NGS) test is used to profile cancers in order to
identify targeted therapies and determine chemotherapeutic tolerance.
Zenome also
unveiled the first decentralised genomic internet software in September 2018,
which is expected to expand the possibilities for safe storing of massive
amounts of genetic data. The key benefit of decentralised genomic internet
software is that it has a significantly higher level of security.
Global Genomics Market Restraints
A major
impediment to the global genomics market's growth is a scarcity of skilled and
trained specialists in genomes research. According to an express healthcare
research from January 2019, genomics studies require highly competent and
trained experts to streamline lab workflows and run them efficiently.
Global Genomics Market Regional Analysis
Due to
increased product releases by key competitors, Europe is likely to earn
considerable market share in the global genomics market over the forecast
period. For example, Illumina, Inc. announced the launch of its new VeriSeq
NIPT Solution in April 2017, which is a CE-IVD-marked next-generation
sequencing (NGS)-based method to non-invasive prenatal testing (NIPT). The
CE-IVD-certified library preparation and analysis software is part of this
strategy. Fast, highly accurate, cost-effective, and non-invasive parenteral
testing is possible with this programme (NIPT).
- Get link
- X
- Other Apps
Comments
Post a Comment